These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 7375013

  • 41. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S, Schieffer M, Jürgens S, Wehner HD, Flehmig B.
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [Abstract] [Full Text] [Related]

  • 42. Role of hepatitis B virus in non-B, non-C chronic liver disease: in vitro proliferation and interferon-gamma production of peripheral blood mononuclear cells in response to hepatitis B core antigen and its relation to hepatitis activity.
    Niigaki M, Fukuda R, Hamamoto S, Ishimura N, Ishihara S, Akagi S, Watanabe M, Kinoshita Y.
    Am J Gastroenterol; 2000 Jan; 95(1):239-47. PubMed ID: 10638591
    [Abstract] [Full Text] [Related]

  • 43. Prognostic analysis in chronic hepatitis B patients: a retrospective study of 216 cases about Scheuer scores, in situ expression of viral antigens and tissue hepatitis B virus DNA levels.
    Zhu R, Huang H, Zhang H, Wang Z, Hu X, Zhai W, Lin Y, Wang J, Zhu H.
    Liver Int; 2006 Feb; 26(1):82-9. PubMed ID: 16420513
    [Abstract] [Full Text] [Related]

  • 44. Chronic asymptomatic HBSAg carriers: histologic abnormalities and diagnostic and prognostic value of serologic markers of the HBV.
    De Franchis R, D'Arminio A, Vecchi M, Ronchi G, Del Ninno E, Parravicini A, Ferroni P, Zanetti AR.
    Gastroenterology; 1980 Sep; 79(3):521-7. PubMed ID: 7429112
    [Abstract] [Full Text] [Related]

  • 45. Diagnosis of hepatitis B virus infection through serological and virological markers.
    Kao JH.
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):553-62. PubMed ID: 19072403
    [Abstract] [Full Text] [Related]

  • 46. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
    Squadrito G, Pollicino T, Cacciola I, Caccamo G, Villari D, La Masa T, Restuccia T, Cucinotta E, Scisca C, Magazzu D, Raimondo G.
    Cancer; 2006 Mar 15; 106(6):1326-30. PubMed ID: 16453330
    [Abstract] [Full Text] [Related]

  • 47. [Histopathological and immunological aspects of chronic active hepatitis].
    Budriesi N, Pigozzi S, Zamboni A, Todarello A, Rizzo S, Campanelli AR.
    G Clin Med; 1982 Jan 15; 63(1):9-16. PubMed ID: 7106460
    [No Abstract] [Full Text] [Related]

  • 48. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z, Mor E, Shapira Z, Tur-Kaspa R.
    Liver Transpl; 2001 Feb 15; 7(2):113-7. PubMed ID: 11172394
    [Abstract] [Full Text] [Related]

  • 49. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L, Vargas V, Rodríguez F, Allende H, Buti M, Sánchez-Avila JF, Jardí R, Margarit C, Pumarola T, Esteban R, Guardia J.
    Liver Transpl; 2002 Oct 15; 8(10):892-900. PubMed ID: 12360430
    [Abstract] [Full Text] [Related]

  • 50. Chronic active hepatitis: immunopathogenesis and immunotherapy.
    Williams R, Eddleston AL.
    Isr J Med Sci; 1979 Mar 15; 15(3):261-75. PubMed ID: 378898
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases.
    Georgiadou SP, Zachou K, Rigopoulou E, Liaskos C, Mina P, Gerovasilis F, Makri E, Dalekos GN.
    J Viral Hepat; 2004 Jul 15; 11(4):358-65. PubMed ID: 15230859
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo.
    Walter E, Keist R, Niederöst B, Pult I, Blum HE.
    Hepatology; 1996 Jul 15; 24(1):1-5. PubMed ID: 8707245
    [Abstract] [Full Text] [Related]

  • 55. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K, Pal NS, Arora SK.
    Indian J Pathol Microbiol; 2006 Jul 15; 49(3):357-61. PubMed ID: 17001884
    [Abstract] [Full Text] [Related]

  • 56. Efficacy of adenine arabinoside 5'-monophosphate in kidney recipients with chronic active hepatitis B: a pilot study.
    Pol S, Saltiel C, Legendre C, Carnot F, Driss F, Berthelot P, Bréchot C, Ruet C, Kreis H.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 2):1446-9. PubMed ID: 7680158
    [No Abstract] [Full Text] [Related]

  • 57. Inapparent "wild-type" and "e-minus variant" HBV infection in patients with HCV-related chronic hepatitis.
    Sardo MA, Rodinò G, Brancatelli S, Pernice M, Campo S, Squadrito G, Russo F, Raimondo G.
    Liver; 1994 Oct 15; 14(5):241-4. PubMed ID: 7997082
    [Abstract] [Full Text] [Related]

  • 58. [Chronic hepatitis: when and how to treat? (author's transl)].
    Paumgartner G.
    Ther Umsch; 1978 Sep 15; 35(9):716-20. PubMed ID: 360473
    [No Abstract] [Full Text] [Related]

  • 59. [Australia antigen and viral hepatitis. Epidemiological, clinical, histological, biochemical and immunological studies].
    Aiuti F, Costa M, Ciarla MV, Gallo IA, Provvidenza G, Lo Sardo S.
    Recenti Prog Med; 1971 Jun 15; 50(6):493-537. PubMed ID: 5171736
    [No Abstract] [Full Text] [Related]

  • 60. [Treatment problems in chronic hepatitis].
    Chernev K.
    Vutr Boles; 1982 Jun 15; 21(1):6-12. PubMed ID: 6178223
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.